News

The study's 19 young participants stuck to their regimens, and along with their parents said that they would be open to continuing treatment sessions. 

Also: More hires from Flare Capital Partners, Greenway Health and Analytics 4 Life.

The Sugar.IQ digital diabetes assistant will use AI analytics to predict users' low blood sugar risk within the next one to four hours.

Otsuka intends to invest more than $300 million in an FDA-cleared software app that will apply cognitive therapy principals either with or without prescription drugs. 

Plus: ResApp files for CE Mark; researchers develop "pacemaker for the brain."

Ongoing FDA submissions and other HHS services are safe, but new regulatory filings will have to be put on hold.

At HIMSS, Dr. Richard Milani will share learnings and data from his health system's chronic condition management initatives.

The infant mortality rate in Franklin County, Ohio, has reached 8.2 deaths per 1,000 live births, with black babies at three times the risk of white infants. 

The prescription device detects each use and records it to a paired mobile app. 

At HIMSS19, University of Chicago Medicine's chief experience officer will describe an ongoing coaching program that aims to restore the connection between humans and the healthcare technologies serving them.